Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials. [electronic resource]
Producer: 20150223Description: 472-86 p. digitalISSN:- 2213-2619
- Administration, Inhalation
- Aged
- Benzyl Alcohols -- administration & dosage
- Bronchodilator Agents -- administration & dosage
- Chlorobenzenes -- administration & dosage
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Combinations
- Female
- Follow-Up Studies
- Forced Expiratory Volume -- drug effects
- Humans
- Male
- Middle Aged
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Quinuclidines -- administration & dosage
- Scopolamine Derivatives -- administration & dosage
- Time Factors
- Tiotropium Bromide
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.